• Military

• WMD Menu                           

• Introduction
• Systems
• Facilities
• Agencies
• Operations
• Countries
• Hot Documents
• News
• Reports
• Policy
• Budget
• Congress
• Links

• Intelligence
• Homeland Security
• Space

STATEMENT BY
BRIGADIER GENERAL STEPHEN V. REEVES
PROGRAM EXECUTIVE OFFICER
FOR THE CHEMICAL AND BIOLOGICAL DEFENSE PROGRAM

BEFORE THE SUBCOMMITTEE ON TERRORISM, UNCONVENTIONAL THREATS AND CAPABILITIES
HOUSE ARMED SERVICE COMMITTEE
UNITED STATES HOUSE OF REPRESENTATIVES

CONCERNING
COUNTERING THE THREAT OF
WEAPONS OF MASS DESTRUCTION TERRORISM

MARCH 19, 2003  

  

Mr. Chairman and Members of the Committee.  I am Brigadier General Stephen V. Reeves, the Program Executive Officer for Chemical and Biological Defense.  We are located in Falls Church, Virginia.  I sincerely appreciate this opportunity to represent the Department of Defense today, and to provide testimony on this important subject. 

 

The mission of the Program Executive Office is to meet the chemical and biological defense medical and nonmedical requirements of our warfighters.  The Program Executive Office for Chemical and Biological Defense executes this mission for all the armed services through the life cycle research, development, procurement and deployment of major end items of Nuclear, Biological and Chemical defense equipment as well as chemical and biological defense medical treatments, vaccines and devices.   Using a focused program management structure, we maintain continuous and effective communication with the science and technology community; the Joint Requirements Office; our warfighters; industry, technical and operational testers and independent evaluators, Service logistics and sustainment activities, and with the Office of the Secretary of Defense and the Congress who have oversight responsibilities. This focused management approach ensures the rapid and effective development and fielding of new capabilities meeting joint service requirements.

  

In accordance with law, The Army is the executive agent for the Department of Defense's Chemical and Biological Defense Program.   The acquisition professionals that lead and make up our project and product management teams come from all of the services allowing us to leverage the very best talent and technical expertise from each.  Collectively, we share the goal of providing our armed forces the best chemical and biological defense medicine and equipment at the right time, at the right place, and at the right cost. 

 

Today, I would like to show you just some of the results of the substantial Congressional support we have received since Desert Storm and the hard work by our joint service acquisition professionals.  The equipment I will highlight is in use in the Gulf region today protecting our men and women from weapons of mass destruction and enabling them to accomplish their mission.

In summary, we are providing our soldiers, sailors, airmen and marines the best technology, training and equipment in the world.  

Again, I sincerely appreciate this opportunity to testify before the subcommittee.  Subject to your questions, this concludes my testimony. 

---